We tested the government’s official new AI nutrition tool: Grok - Top-Institutions - MDSpire

We tested the government’s official new AI nutrition tool: Grok

  • By

  • Sarah Todd

  • February 10, 2026

  • 0 min

Share

Top Institutions in Family Medicine

Brief introduction explaining scope and methodology.

  • #1

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, MA

    Key Differentiators

    • Nutrition Science
    • Epidemiology
    • Public Health Policy

  • #2

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Nutrition Policy
    • Epidemiology
    • Health Informatics

  • #3

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Nutrition Epidemiology
    • Health Behavior
    • AI in Healthcare

  • #4

    Tufts University Friedman School of Nutrition Science and Policy
    Tufts University Friedman School of Nutrition Science and Policy

    Boston, MA

    Key Differentiators

    • Nutrition Science
    • Food Policy
    • Public Health Nutrition

  • #5

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Clinical Nutrition
    • Health Informatics
    • AI in Medicine

Original Source(s)

We tested the government’s official new AI nutrition tool: Grok

  • by Sarah Todd

  • February 10, 2026

Related Content

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.